Pranlukast hemihydrate is a selective cysteinyl leukotriene receptor-1 antagonist used in the clinical management of bronchial asthma to inhibit the inflammatory effects of leukotrienes. This category… Read more











Pranlukast hemihydrate is a selective cysteinyl leukotriene receptor-1 antagonist used in the clinical management of bronchial asthma to inhibit the inflammatory effects of leukotrienes. This category encompasses a comprehensive selection of reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these high-quality materials to facilitate rigorous analytical testing, impurity profiling, and method validation. By providing consistent standards for comparison, these compounds support essential quality control processes, ensuring regulatory compliance and the accuracy of stability studies during drug development and manufacturing. Whether developing new detection methods or performing routine batch release testing, researchers rely on these specialized chemical tools to maintain the precision and reliability of their analytical protocols.